Evaluation off Monoclonal Antibodies for the Development off Breast Cancer Immunotoxins

M. J. Bjorn, D. Ring, A. Frankel

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Eighty-five antibodies recognizing breast cancer-selective antigens were conjugated to ricin toxin A-chain using a disulfide linkage. The cytotoxicities of the resulting immunotoxins were determined on breast cancer cells and normal human fibroblasts. Twenty-four antibodies formed immunotoxins that were toxic to at least one breast cancer cell line at concentrations of 10 nM or less but were nontoxic to human fibroblast lines used as negative controls. Some of the breast tumor-selective immunotoxins were as toxic as a conjugate beteen monoclonal anti-transferrin receptor and ricin toxin A-chain (50% inhibition of cellular protein synthesis at approximately 0.1 nM). Another set of four immunotoxins were indiscriminately toxic to human breast tumor cell lines, two human fibroblast cell lines, and a human lymphoblastoid line. Several of the antibodies the toxin conjugates of which specifically killed breast cancer cell lines may be useful in cancer therapy, since they show a wide range of binding to individual breast tumors and cell lines and a limited range of binding to normal tissue types.

Original languageEnglish (US)
Pages (from-to)1214-1221
Number of pages8
JournalCancer research
Issue number3
StatePublished - Mar 1 1985

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Evaluation off Monoclonal Antibodies for the Development off Breast Cancer Immunotoxins'. Together they form a unique fingerprint.

Cite this